Fresenius Group Overview

The Health Care Group
Stories
Archive „Stories“
Investors
Contact

Fresenius SE & Co. KGaA

Investor Relations

+49 (0) 6172 608-2485
ir-fre@fresenius.com
Media
- News
- Social Media
- Calendar
- Contacts
- Media Center
Contact

Matthias Link

Vice President Corporate Communications

T: +49 (0) 6172 608-2872
matthias.link@fresenius.com
Careers
Menu
Filter results
- Fresenius Websites
- Chapter
- Format
  - Website (0)
  - PDF (0)
Share
- Facebook
- Twitter
- LinkedIn
- Xing
- Google+
- E-Mail
Services
- Deutsch
- Print
- Contact
- RSS

A little heart at the center of a complex surgery

For more than 20 years, Fresenius Helios’ Leipzig Heart Center has been providing highest quality cardiac care – sometimes to very young patients.
Read the story
On duty in disaster zones

Fresenius employees help patients – and each other – after catastrophic hurricanes.
Read the story
Crucial lessons learned

Faced with one of the ‘superbugs’ that pose a huge health threat worldwide, Fresenius Helios turned to advanced hygiene management.
Read the story
More ‘Quality of Life’ in clinics

Fresenius Medical Care Argentina patients enjoy fitness and therapy activities during treatments.
Read the story

News

Fresenius terminates merger agreement with Akorn

April 22, 2018Fresenius Kabi

Fresenius Medical Care releases preliminary Q1 figures

April 22, 2018Fresenius Medical Care
Fresenius Medical Care sells Sound Inpatient Physicians Holdings for $2.15 billion

Fresenius Medical Care today announced an important strategic step to sharpen its U.S. Care Coordination profile with the signing of a definitive agreement to divest its controlling interest in Sound Inpatient Physicians Holdings, LLC to an investment consortium led by Summit Partners, for total transaction proceeds of ...
April 21, 2018Fresenius Medical Care

Fresenius Kabi expands production site for medical devices in Dominican Republic

April 20, 2018Fresenius Kabi
Brief News
Fresenius Helios opens new ICU in Tenerife

Quirónsalud Tenerife Hospital has opened a new intensive care unit, equipped with the latest medical equipment for treating as many as six critically ill patients at a time. Quirónsalud, the Spanish hospital group that is part of Fresenius Helios, invested more than €1 million in the 400-square-meter (4,300-square-foot) ICU.

April 06, 2018Fresenius Helios

Fresenius starts work on new R&D building in Bad Homburg

March 22, 2018Fresenius
Potentialpark study 2018 shows Fresenius provides Germany’s best online offering for job applicants

March 06, 2018Fresenius

Fresenius remains on growth course after 14 straight record years

February 26, 2018Fresenius
Fresenius Medical Care achieves record results in 2017 and targets strong net income growth in 2018

February 26, 2018Fresenius Medical Care

Brief News
Fresenius Helios expands two hospitals in Germany

Fresenius Helios recently opened a 130-bed building at the company’s hospital in Dachau, a city near Munich. The new structure is part of a €55 million renovation and expansion program that will include a modernization of the existing hospital building over the next two years. Meanwhile, in the northern German city of Nienburg/Weser, work has started on a building that will almost double the size of the emergency department at Fresenius Hospital Mittelweser. About €2.3 million is being invested in this project, which is scheduled for completion in the autumn.

February 20, 2018Fresenius Helios
Brief News
Fresenius Helios presents inaugural science prize

Fresenius Helios has presented the new Helios Science Prize for outstanding research by employees that contributes to improved treatment quality. The three winners all work at hospitals in Germany and were honored for their work in different areas of medicine. The prize, which comes with a cash award, went to Dr. Jitka Veldema of Helios Hospital Kipfenberg (for her work on stroke rehabilitation), Prof. Dr. Alexander Kreuter of Helios St. Elisabeth Hospital in Oberhausen (cancer diagnosis in HIV patients), and Dr. Patrick Weil of Helios University Hospital in Wuppertal (testicular cancer therapy).

February 02, 2018Fresenius Helios

Brief News
S&P lifts Fresenius' rating outlook to positive

Standard & Poor’s has revised Fresenius’ corporate credit outlook to positive from stable in late December 2017. The corporate credit rating was affirmed. Hence, Fresenius is now rated BBB- with positive outlook by Standard & Poor’s. Fresenius is rated investment grade by all of the three leading rating agencies Standard & Poor’s, Moody's and Fitch.

January 19, 2018Fresenius
Brief News
Fresenius Vamed wins awards for spa and wellness facilities

VAMED Vitality World has been named the “World’s Best Thermal Spa & Medical Wellness Operator 2017” at the World Spa Awards. Three VAMED Vitality World facilities – St. Martins Thermal Spa & Lodge and Thermal Spa Laa Hotel & Spa, both in Austria, and Aquaworld Resort Budapest in the Hungarian capital – also won in their individual categories. VAMED Vitality World, part of Fresenius Vamed, operates a total of nine spa and health resorts in Austria and Hungary.

January 16, 2018Fresenius Vamed

Fresenius expects meaningful positive effects from U.S. tax reform

December 22, 2017Fresenius
Fresenius Medical Care expects material positive effects from U.S. tax reform

December 22, 2017Fresenius Medical Care

Brief News
Fresenius Helios builds new hospital in Spain

Quirónsalud, the Spanish hospital group that is part of Fresenius Helios, will build a hospital in the city of Alcalá de Henares, just outside of Madrid. The approximately 11,000-square-meter (118,000-square-foot) facility will include 106 beds, four operating rooms and two delivery rooms. Quirónsalud will invest about €27 million in the new hospital. It is scheduled to open in 2019.

December 20, 2017Fresenius Helios
Unicyte AG, regenerative medicine unit of Fresenius Medical Care, appoints Jonathan Knowles to Scientific Advisory Board

December 19, 2017Fresenius Medical Care

Brief News
Fresenius submits first biosimilar Marketing Authorization Application

Fresenius Kabi has submitted a Marketing Authorization Application to the European Medicines Agency for its adalimumab biosimilar candidate of Humira®. The application is the first biosimilar regulatory filing for Fresenius Kabi. Adalimumab is approved in the EU for use in the treatment of chronic inflammatory autoimmune conditions, including different types of arthritis or Crohn's disease.

December 18, 2017Fresenius Kabi
Fresenius Medical Care closes divestment of Shiel Medical Laboratory to Quest Diagnostics

December 12, 2017Fresenius Medical Care

Fresenius Kabi opens extension at production plant in Mihla, eastern Germany

December 01, 2017Fresenius Kabi
Fresenius Medical Care achieves improved health outcomes and savings in Demonstration Program in the United States

November 27, 2017Fresenius Medical Care

Brief News
Fresenius Kabi opens production facility in Indonesia

Fresenius Kabi is expanding its activities in Indonesia. PT ETHICA Industri Farmasi, a joint venture of Fresenius Kabi and the Indonesian pharmaceuticals company SOHO Global Health, opened a new plant in Cikarang, just outside the country’s capital and biggest city Jakarta. The plant’s approximately 230 employees will produce a wide range of injectable drugs needed in therapeutic areas including gynecology, anesthesia and intensive care. The products are planned for use by Indonesian patients and for export to other Southeast Asian countries. Fresenius Kabi employs a total of about 530 people in Indonesia.

November 24, 2017Fresenius Kabi
Brief News
Fresenius Vamed acquires third Swiss rehabilitation clinic

Fresenius Vamed has acquired a rehabilitation clinic in Switzerland, its third in the country. The clinic in Seewis has about 75 beds and specializes in heart disease, internal medicine and psychosomatic illnesses. Fresenius Vamed is now active in all major areas of rehabilitative medicine in Switzerland, with a clinic in Zihlschlacht that specializes in neurology and one in Dussnang specializing in orthopedics and geriatrics.

November 08, 2017Fresenius Vamed

Fresenius reports another strong quarter and confirms guidance

November 02, 2017Fresenius
Fresenius Medical Care delivers solid Q3 despite impact from natural disasters in North America

November 02, 2017Fresenius Medical Care

Fresenius Medical Care with strong contribution to research at world’s largest gathering of kidney professionals

November 01, 2017Fresenius Medical Care
NxStage shareholders approve merger agreement with Fresenius Medical Care – Closing expected to occur in 2018

October 27, 2017Fresenius Medical Care

Brief News
Fresenius Vamed opens Institute for Gender Medicine

Fresenius Vamed has opened the Institute for Gender Medicine in cooperation with the Medical University of Vienna. This new research institute, in the Lower Austria town of Gars am Kamp, will focus on the different needs of female and male patients, for example in the interpretation of disease symptoms. Fresenius Vamed will be able to use the institute’s research findings to develop tailored treatment offerings in areas such as prevention and rehabilitation. The Institute for Gender Medicine complements initiatives for individualized medical care already being carried out by the VAMED International Medical Board and its approximately 650 physicians.

October 19, 2017Fresenius Vamed
Brief News
Fresenius Helios expands university hospital in Madrid

Quirónsalud, the Spanish hospital group that is part of Fresenius Helios, is undertaking a major expansion of University Hospital Quirónsalud Madrid. A new, 6,000-square-meter (almost 65,000-square-foot) wing scheduled for completion by next summer will add 52 new beds, bringing the hospital’s total to 288. The expansion will also include 25 doctors’ offices, nine resuscitation rooms and three delivery rooms, as well as two hybrid operating rooms that can be used both for conventional operations and for minimally invasive surgical procedures – so-called “keyhole surgery.” All expansion and modernization measures should be completed by the end of 2018. The total investment is about €31 million.

October 04, 2017Fresenius Helios

Fresenius lays cornerstone for new building at headquarters in Bad Homburg

September 29, 2017Fresenius